Are you Dr. McMahon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 W Dry Creek Cir
Littleton, CO 80120Phone+1 303-730-4700Fax+1 303-730-4790
Summary
- Dr. Richard McMahon, MD is an oncologist in Littleton, Colorado. He is currently licensed to practice medicine in Colorado, Minnesota, and Illinois. He is affiliated with AdventHealth Littleton, AdventHealth Porter, and Sky Ridge Medical Center.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1976 - 1978
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1973 - 1976
- Northwestern University The Feinberg School of MedicineClass of 1973
Certifications & Licensure
- IL State Medical License 1974 - Present
- CO State Medical License 2017 - 2025
- MN State Medical License 1976 - 1979
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. Start of enrollment: 2013 May 14
Publications & Presentations
PubMed
- 21 citationsPhase II Trial of Capecitabine and Weekly Paclitaxel in Patients with Metastatic Breast Cancer Previously Treated with Every-3-Week Taxane TherapyJoanne L. Blum, E. Claire Dees, Svetislava J. Vukelja, Mammo Amare, David P. Gill
Clinical Breast Cancer. 2007-02-01 - 50 citationsPhase II Trial of Capecitabine and Weekly Paclitaxel As First-Line Therapy for Metastatic Breast CancerJoanne L. Blum, E. Claire Dees, Aparna Chacko, Lisa Doane, Sukumar Ethirajan
Journal of Clinical Oncology. 2006-09-20